Private Equity

Updated:

Lyzz Capital

LYZZ Capital is a China-based healthcare, growth, and M&A fund. Founded in 2014, it is a private equity firm that seeks to invest in companies operating in...

Lyzz Capital logo

Lyzz Capital

LYZZ Capital is a China-based healthcare, growth, and M&A fund. Founded in 2014, it is a private equity firm that seeks to invest in companies operating in healthcare, medical devices, and related fields.

General information

Firm type

Private Equity

Year founded

2014

Location

Region

Asia

Country

China

City

Shanghai

Corporate office

Shanghai, China

Frequently asked questions

What investment stages does Lyzz Capital typically target?

Lyzz Capital's stated strategy covers the full spectrum of venture capital, from early-stage seed and start-up rounds through expansion and late-stage growth financing. This stage-agnostic mandate allows it to deploy initial checks and follow-on capital across a company's lifecycle. The firm has not publicly disclosed minimum or maximum check sizes.

Does Lyzz Capital disclose its assets under management or fund vintages?

Lyzz Capital does not publicly report assets under management, fund sizes, or specific fund vintage years. This level of opacity is typical for onshore Chinese private equity firms that raise capital exclusively from domestic investors and are not subject to the disclosure norms required by global institutional limited partners.

What is Lyzz Capital's posture on co-investments alongside external managers?

There is no public information on whether Lyzz Capital participates in co-investments alongside external general partners or if it syndicates deals with other venture firms. Many generalist venture firms in China do syndicate to share due diligence burdens and expand access, but Lyzz has not confirmed this practice.

Which sectors does Lyzz Capital focus on, and which does it explicitly avoid?

Lyzz Capital describes its strategy as general venture capital and has not published specific sector concentrations. Common investment areas for Shanghai-based generalist funds include enterprise software, AI/ML, industrial technology, and healthcare services. The firm has not published a formal exclusion list, though it operates in a regulatory environment where sectors like consumer internet gaming and cryptocurrency face significant state scrutiny.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Shanghai Private Equity profiles